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Abstracts / Urological Science 26 (2015) S36eS49 S39known. PBNO is a videourodynamic (VUD) diagnosis. The classic presence
of VUD study is high pressure and low ﬂow voiding pattern without
dysfunction of extrinsic sphincter relaxation and distal urethral
obstruction.
Here we presented a 30-year-old male who has difﬁculty voiding. Uro-
ﬂowmetry showed intermittent voiding pattern and low ﬂow rate.
Cystoscopy didn't reveal distal urethral stricture and benign prostatic hy-
perplasia. Videourodynamic study showed high pressure, low ﬂow voiding
pattern. After alpha block medical therapy failed, transurethral bladder
neck incision over 5 and 7 o'clock bidirectional was performed. After
surgery, his urinary ﬂow rate increased. Uroﬂowmetry showed normal
ﬂow pattern with 37 c.c./sec. maximal ﬂow rate. The recovery course was
uneventful and he was satisﬁed with surgical result.
MP2-3.
5-ALPHA-REDUCTASE INHIBITORS AND RISK OF CARDIOVASCULAR
DISEASES
Teng-Fu Hsieh 1,2, Shang-Sen Lee 1,2, Tien-Huang Lin 1,2, Hsin-Ho
Liu 1,2, Tsung-Hsun Tsai 1,2, Chi-Cheng Chen 1,2. 1Department of Urology,
Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung,
Taiwan; 2 School of Medicine, Tzu Chi University, Hualian, Taiwan
Purpose: The aim of this study is to investigate the risk of cardiovascular
diseases after 5-alpha-reductase inhibitor (5ARI) therapy for benign
prostate hyperplasia (BPH) using the National Health Insurance Research
Database (NHIRD) in Taiwan.
Materials and methods: In total, 1,486 adult patients newly diagnosed
with BPH andwho used 5-alpha-reductase inhibitors were recruited as the
study cohort, along with 9,995 subjects who did not use 5-alpha-reductase
inhibitors as a comparison cohort. Each patient was monitored for 5 years,
and those who subsequently had cardiovascular diseases were identiﬁed.
A Cox proportional hazards model was used to compare the risk of car-
diovascular diseases between the study and comparison cohorts after
adjusting for possible confounding risk factors.
Results: The patients who received 5ARI therapy had a lower cumulative
rate of cardiovascular diseases than those who did not receive 5ARI therapy
during the 5-year follow-up period (8.4% vs. 11.2%, P ¼ 0.003). In subgroup
analysis, the 5-year cardiovascular event hazard ratio (HR) was lower
among the patients older than 65 years with 91 to 365 cumulative deﬁned
daily dose (cDDD) 5ARI use (HR ¼ 0.63, 95% conﬁdence interval (CI) 0.42 to
0.92; P ¼ 0.018), however there was no difference among the patients with
28 to 90 and more than 365 cDDD 5ARI use (HR ¼ 1.14, 95% CI 0.77 to 1.68;
P ¼ 0.518 and HR ¼ 0.83, 95% CI 0.57 to 1.20; P ¼ 0.310, respectively).
Conclusion: The present study indicated that 5ARI therapy was safe and
did not increase the risk of cardiovascular events in the BPH patients in 5
years of follow-up. Further mechanistic research is needed.
MP2-4.
ASSOCIATION OF PROSTATE BLOOD FLOW WITH MALE LOWER
URINARY TRACT SYMPTOMS
Kuan-Yu Wu, Yuh-Shyan Tsai, I-Hung Chen, Yung-Ming Lin, Tzong-Shin
Tzai, Yat-Ching Tong. Department of Urology, College of Medicine and
Hospital, National Cheng Kung University, Tainan, Taiwan
Purpose: To investigate the association of prostate blood ﬂow with lower
urinary tract symptoms in aged male using Doppler spectral waveform
(DSW) analysis.
Materials and methods: We performed a prospective analysis involving
133 aged male patients with clinically imaged benign prostatic hyperpla-
sia. DSW parameters [peak-systolic velocity (PSV), end-diastolic velocity
(EDV), and resistive index (RI)] were measured at bilateral neurovascular
bundle (NVB) vessels and their urethral and capsular branches via Doppler
transrectal ultrasound at the right lateral decubitus position. The associ-
ation of these parameters with lower urinary tract symptoms scred with
international prostate symptom score (IPSS) were analyzed.
Result: Overall, total IPSS scores were signiﬁcantly associated with RI of
each NVB vessels (r2 ¼ 0.03, 0.04; p ¼ 0.04, 0.02, respectively), as well as
PSV of left PSV vessels. PSV of both NVB vessels is associated with the
storage score (p¼ 0.022 and 0.016), rather thanwith the voiding score. Thesummation of frequency and urgency score is also associated with EDV of
bother capsular and urethral branches (p ¼ 0.043 and 0.009, respectively),
as well as PSV of NVB vessels at both sides (p ¼ 0.045 and 0.019,
respectively).
Conclusion: The association of prostate blood ﬂow and lower urinary tract
symptoms exists, mainly with storage symptoms. This ﬁndingmay provide
some information in searching the underlying the etiology.
MP2-5.
UROTHELIAL DYSFUNCTION AND CHRONIC INFLAMMATION IN
PATIENTS WITH BLADDER OUTLET OBSTRUCTION AND DIFFERENT
BLADDER DYSFUNCTION AND DIFFERENT BOO DEGREE
Cheng-Ling Lee, Hann-Chorng Kuo. Department of Urology, Buddhist Tzu
Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Purpose: Bladder outlet obstruction (BOO) may be induced by a wide
range of functional and/or anatomic causes. The resulting obstruction
frequently produces bothersome lower urinary tract symptoms (LUTS) in
patients. The underlying mechanisms responsible for the bladder
dysfunction in BOO remain poorly understood. The purpose of this study is
to investigate the urothelial dysfunction and chronic inﬂammation in pa-
tients with BOO.
Materials and methods: In this prospective study, we enrolled those pa-
tients who presented with LUTS and underwent urodynamic study (VUDS)
for further evaluation. Based on their VUDS performances, it was catego-
rized into 4 sub-groups: control, BOO with detrusor overactivity (DO), BOO
with Detrusor underactivity (DU) and BOO with hypersenstivity bladder
(HSB). Bladder tissues taken from these patients were analyzed. Immu-
noﬂuorescence (IF) staining of junction protein E-cadherin, mast cell,
TUNEL and Zo-1 were performed. The ﬂuorescence intensity of E-cadherin
was measured using an Image J method. The percentage of activated mast
cells and apoptotic cells were measured and quantiﬁed as positive cells per
area unit (4 mm2). The numbers of positive protein were correlate with
VUDS parameters.
Results: A total of 44 men were enrolled in this study. There were 34
patients presented with BOO (DO: 12, DU: 11 and HSB: 11). The expression
and cellular location of E-cadherin, mast cell, TUNEL and Zo-1 were
illustrated in Fig.1. The distribution of E-cadherin is signiﬁcantly reduced in
BOO with DU (8.37 ± 9.50) (p < 0.000), whereas exhibit highest number of
TUNEL (3.60 ± 3.43) (p<0.021). The tryptase signal in BOO with DO is
signiﬁcantly increased (19.05 ± 6.14) (p < 0.000). All these parameters do
not show positive correlation with AbramseGrifﬁths (AG) number.
Increasing number of E-cadherin is associated with Pdet and Qmax.
Tryptase/ mast cell is positively associated with FSF.
Conclusion: In this study, we have shown that LUTS secondary to BOO are
associated with chronic urothelial inﬂammation and urothelial dysfunc-
tion. DU induced by BOO is associated with signiﬁcant urothelial defection.
This may imply that the loss of functional protein and urothelial cell
apoptosis might contribute to the pathophysiology of bladder dysfunction
in BOO.
MP2-6.
THE ROLE OF CHITOSAN IN TREATMENT INTERSTITIAL CYSTITIS
Dong-Ru Ho 1,2,3, Chih-Shou Chen 1, Wei-Yu Lin 1,3, Yun-Chin
Huang 1,2, Jian-Hui Lin 1. 1Division of Urology, Department of Surgery,
Chang Gung Memorial Hospital, Taiwan; 2Graduate Institute of Clinical
Medical Sciences, Chang Gung University, Taiwan; 3Department of Nursing,
Chang Gung University of Science and Technology, Taiwan
Purpose: Since glycosaminoglycans plays an important role in the path-
ophysiology and treatment of interstitial cystitis, we hope to investigate
the potential beneﬁt of small molecular chitosan, which is the monomer of
glycosaminoglycans, in the treatment of cyclophosphamide induced
interstitial cystitis rat model.
Materials and methods: We used cyclophosphamide (CYP) intraperito-
neal injection to induced chronic cystitis in female rats. Treatment with
intravesical chitosan instillation was performed along with cystitis in-
duction. Cystometrogram was performed to evaluate intravesical pressure
and intercontraction interval.
Abstracts / Urological Science 26 (2015) S36eS49S40Results: There was signiﬁcant difference in intravesical pressure and inter-
contraction interval when rats treated with chitosan. Systemic cytokines
including IL-6andTNF-a increased inCYPratswhile IL-10and IFN-rdecreased.
The trend is mildly reversed in IL-10 when intravesical chitosanwas applied.
Conclusions: Chitosan may potentiate the effect of cyclophosphamide.
Spleen cytokines changes indicated that locally applied chitosanmay affect
systemic response in rats. Intravesical chitosan had a role further more
than a coating agent in bladder.
MP2-7.
IDENTIFYING THE VARIABLES ASSOCIATED WITH PAIN DURING
TRANSRECTAL ULTRASONOGRAPHY OF THE PROSTATE
Chen-Pang Hou MD, Phei-Lang Chang MD, Chien-Lun Chen MD, PhD, Yu-
Hsiang Lin MD, Chou Chih-Yuan, Ke-Hung Tsui MD. Department of Urology,
Chang Gung Memorial Hospital, Taoyuan, Taiwan
Purpose: The purpose of this study was to prospectively investigate the
degree of pain experienced by patients receiving transrectal ultrasonog-
raphy (TRUS) of the prostate by applying a visual analogue scale (VAS). We
also identiﬁed the clinical parameters inﬂuencing pain during the TRUS
examination.
Materials and methods: Records were obtained from a prospective
database for male patients who received TRUS of prostate in the outpatient
department of Chang-Gung Memorial Hospital, Taiwan, from January 2014
to June 2014. The patients underwent a detailed physical examination and
medical history review. Immediately after the TRUS examination, the pa-
tients completed questionnaires based on a 10-point visual analogue pain
scale. The variables of interest were age, body mass index, prostate vol-
ume, prostate sagittal length, prostatic speciﬁc antigen, previous TRUS
experience, external hemorrhoids, anal surgical history, prostate calciﬁ-
cation, and image artifact caused by stool in the rectum. All variables were
correlated to the VAS by applying multivariate regression analysis.
Results: By using linear regression analysis, we identiﬁed the independent
factors that affected the pain score during the TRUS examination. The
patients who received the examination for the ﬁrst time or had longer
prostate sagittal lengths, external hemorrhoids, anal surgical history, or
stool stored in the rectum all experienced more pain during the TRUS
examination. Furthermore, the pain was reduced when we provided the
patients with a detailed explanation before the procedure and allowed
them to observe the real-time image during the examination
Conclusions: Although a TRUS examination is uncomfortable for patients,
after having identiﬁed the factors affecting pain, physicians can assist
patients in reducing pain during the procedure, thus providing higher
quality examinations.Female Urology & Urodynamics
MP2-8.
INCREASED RISK OF ISCHEMIC STROKE AMONG WOMEN WITH
BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS: A COHORT STUDY
FROM TAIWAN
Shiu-Dong Chung 1,2, Sudha Xirasagar 3, Ching-Chun Lin 4, Wells
Ling 5, Hsien-Chang Li 6, Herng-Ching Lin 2,6,*. 1Division of Urology,
Department of Surgery, Far Eastern Memorial Hospital, Ban Ciao, Taipei,
Taiwan; 2 Sleep Research Center, Taipei Medical University Hospital, Taipei,
Taiwan; 3Arnold School of Public Health, Department of Health Services
Policy and Management, University of South Carolina, Columbia, South
Carolina, USA; 4Department of Psychology, Saint Louis University, St. Louis,
Missouri, USA; 5Graduate Institute of Biomedical Informatics, College of
Medical Science and Technology, Taipei Medical University, Taipei, Taiwan;
6 School of Health Care Administration, Taipei Medical University, Taipei,
Taiwan
Purpose: Vascular factors are proposed in the etiology of bladder pain
syndrome/interstitial cystitis (BPS/IC). In this study, we investigated the* Corresponding author.risk of stroke among women following a diagnosis of BPS/IC over 3 years of
follow-up, compared to controls without a BPS/IC diagnosis.
Materials and methods: This retrospective cohort study used data
retrieved from the Taiwan ‘‘Longitudinal Health Insurance Database 2000.’’
We identiﬁed 847 women who received a diagnosis of BPS/IC between
January 1, 2001 and December 31, 2008 (study group) and 4,235 com-
parison women (women without a BPS/IC diagnosis matched on age and
other selected demographic variables. All subjects were tracked for 3 years
following the index date to identify those who received a diagnosis of
stroke during follow-up.
Results: The stroke incidence rate was 20.86 (95% conﬁdence interval (CI):
15.78e27.07) and 11.65 (95% CI: 9.88e13.64) per 1,000 person-years
among the study and comparison cohorts, respectively. Cox regression
analysis showed a stroke hazard ratio (HR) of 1.52 (95% CI: 1.09e2.14) in
the BPS/IC group relative to the comparison group over 3-year follow-up,
after adjusting for hypertension, diabetes, coronary heart disease, atrial
ﬁbrillation, hyperlipidemia, and chronic kidney disease. The adjusted HR of
ischemic stroke was 1.52 (95% CI: 1.02e2.27). However, there was no
signiﬁcant difference between the two groups in hemorrhagic stroke risk.
Conclusions: Our study demonstrates an association between BPS/IC and
a subsequent ischemic stroke diagnosis among women in Taiwan. Neuro-
urol. Urodynam. 34:44e49, 2015. # 2013 Wiley Periodicals, Inc.
MP2-9.
PRIMARY EXPERIENCES OF SINGLE INCISION MIDURETHRAL SLING IN
WOMEN WITH STRESS URINARY INCONTINENCE
Chia-Shen Chien, Yuan-Chi Shen, Yao-Chi Chuang. Department of Urology,
Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung
University College of Medicine, Kaohsiung, Taiwan
Purpose: We present our preliminary experience of single-incision mid-
urethral sling (ADJUST and MiniArc) in women with stress urinary incon-
tinence (SUI).
Materials and methods: Four patients had mixed urinary incontinence
(MUI) and the other 4 had only SUI, while one of them had concomitant
cystocele. Half of the patients with MUI and SUI received ADJUST while
MiniArc was applied for the others. Cystocele was repaired simultaneously
with anterior Elevate system. Subjective cure was deﬁned as no report of
leakage with coughing or exercise on validated International Consultation
on Incontinence Questionnaire-Urinary Leakage-Short Form (ICIQ-UI-SF).
Operation time, Foley indwelling time, hospital stay, perioperative post-
void residual urine (PVR) and uroﬂow study were documented as well.
Results: Signiﬁcant subjective improvement of urinary incontinence was
observed in all patient groups. Only one patient had prominent PVR
(110ml) after ADJUST sling surgery but no eminent decrease of Qmax.
Another patient self-reported as symptoms improvement instead of cure
due to persistent urinary urgent incontinence (UUI). MiniArc claimed
shorter operation time (from 10min to 20min), while ADJUST sling needed
a longer operation time (from 20 min to 30 min). Foley was removed one
day after operation except in patient with combined cystocele repaired
(Foley removed 2 days after operation).
Conclusion: The current primary results showed optimal outcome of
subjective improvement in patients with SUI or MUI with mean follow up
between 1 month to 1 year. Modern single incision sling is easy to perfrom
without signiﬁcant complications. Further objective outcomes and longer
follow-up are needed to draw the conclusions.
MP2-10.
INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) IS NOT
RELATED TO BLADDER CANCER: A NATIONWIDE POPULATION-BASED,
PROPENSITY SCOREeMATCHED COHORT STUDY
Ming-Huei Lee 1,2, Wei-Chih Chen 1, Huei-Ching Wu1,2. 1Department of
Urology, Fong Yuan Hospital, Ministry of Health and welfare, Taiwan;
2Central Taiwan University of Science and Technology, Taiwan
Purpose: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a highly
prevalent debilitating chronic condition characterized by bladder pain and
